Rasha M. Allam

Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells

Rasha M. Allam, Ahmed M. Al‐Abd, Alaa Khedr et al. · Toxicology Letters · 2018 · 243 citations

Estrogen Metabolism, Urology, Medicine +10

Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases

Perihan A. Elzahhar, Shrouk M. Abd El Wahab, Mohamed Elagawany et al. · European Journal of Medicinal Chemistry · 2020 · 76 citations · Full text

Tumor-associated Carbonic Anhydrases, Medicinal Chemistry, Biochemistry +9

Formulation and characterization of propolis and tea tree oil nanoemulsion loaded with clindamycin hydrochloride for wound healing: In-vitro and in-vivo wound healing assessment

Menna M. Abdellatif, Yara E. Elakkad, Ahmed A.EL-Wakeel et al. · Saudi Pharmaceutical Journal · 2021 · 66 citations · Full text

Promising targets of chrysin and daidzein in colorectal cancer: Amphiregulin, CXCL1, and MMP-9

Abeer Salama, Rasha M. Allam · European Journal of Pharmacology · 2020 · 65 citations

Oncology, Chemoprevention Strategy, Medicine +9

Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities

Asmaa Ahmed, Mamdouh F. A. Mohamed, Rasha M. Allam et al. · Bioorganic Chemistry · 2022 · 51 citations

Medicinal Chemistry, Polymer-drug Conjugate, Medicine +9